NCT01330524

Comparison of Intravitreal Bevacizumab and Triamcinolone With Placebo

Comparison of Intravitreal Bevacizumab and Triamcinolone With Placebo in Acute Nonarteritic Anterior Ischemic Optic Neuropathy

• Status: Unknown
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 16 (estimated)
• Sponsor: Shahid Beheshti University of Medical Sciences · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

In this study 16 Patients diagnosed with Nonarteritic Anterior Ischemic Optic Neuropathy(NSION) who had a sudden mono ocular vision loss associated with optic disc edema and positive Marcus Gunn in less than 30 days without exclusion criteria are randomly divided in two groups 1) control 2) case. In case group Avastin and Triamcinolone will be injected trough vitreal and placebo will be injected in control group. BCVA and Visual field will be then measured in these two groups.

Conditions

• Acute Nonarteritic Anterior Ischemic Optic Neuropathy

Interventions

Type	Name	Description
DRUG	Avastin and Triamcinolone	1.25 mg Avastin and 2mg Triamcinolone will be injected trough vitreal
OTHER	placebo	2mg placebo

Timeline

• Start date: 2010-01-01
• Primary completion: 2010-11-01
• Completion: 2011-11-01
• First posted: 2011-04-07
• Last updated: 2011-04-07

Locations

1 site across 1 country: Iran